Research progress on delivery strategies combining DNA nanostructures and plant-derived bioactive compounds for cancer treatment

Plant-derived anticancer compounds, including vinblastine (VBL), camptothecin (CPT), and paclitaxel (PTX), have attracted considerable interest in cancer therapy. Although VBL and PTX are established chemotherapeutic agents, the clinical development of CPT itself has been limited by poor aqueous solubility, instability under physiological conditions, and toxicity. DNA nanostructures, polymeric and lipid-based nanocarriers, and aptamer-functionalized delivery systems offer potential strategies to address these limitations. This review summarizes representative strategies for the delivery of VBL, CPT, and PTX, with particular emphasis on the distinct roles of DNA nanostructures as drug carriers, plasmid DNA as a genetic payload, and DNA aptamers such as AS1411 as targeting ligands. Drug incorporation mechanisms, including covalent conjugation, non-covalent loading, and encapsulation, are distinguished from co-delivery strategies involving multiple therapeutic payloads. Representative applications of DNA nanostructures and AS1411-functionalized nanocarriers in preclinical cancer research are reviewed, with attention to their delivery mechanisms and potential limitations. Furthermore, analytical characterization, drug-release behavior, carrier stability, and major challenges in clinical translation are considered. Although these approaches have demonstrated promising results in preclinical studies, further investigation of their pharmacokinetics, safety, reproducibility, and therapeutic efficacy is required to support clinical development.

Authors

Institutions

Publication Details

Journal
Biomedical Analysis
Published
2026-11-14
DOI
https://doi.org/10.1016/j.bioana.2026.11.001
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Research progress on delivery strategies combining DNA nanostructures and plant-derived bioactive compounds for cancer treatment

Ailing Su, Jun Ai, Lu Ga, Lan Yu et al.
Biomedical Analysis
Nanoparticle-Based Drug Delivery
article

Research progress on delivery strategies combining DNA nanostructures and plant-derived bioactive compounds for cancer treatment

Ailing Su, Jun Ai, Lu Ga, Lan Yu, Xin Tong
article en

Abstract

Plant-derived anticancer compounds, including vinblastine (VBL), camptothecin (CPT), and paclitaxel (PTX), have attracted considerable interest in cancer therapy. Although VBL and PTX are established chemotherapeutic agents, the clinical development of CPT itself has been limited by poor aqueous solubility, instability under physiological conditions, and toxicity. DNA nanostructures, polymeric and lipid-based nanocarriers, and aptamer-functionalized delivery systems offer potential strategies to address these limitations. This review summarizes representative strategies for the delivery of VBL, CPT, and PTX, with particular emphasis on the distinct roles of DNA nanostructures as drug carriers, plasmid DNA as a genetic payload, and DNA aptamers such as AS1411 as targeting ligands. Drug incorporation mechanisms, including covalent conjugation, non-covalent loading, and encapsulation, are distinguished from co-delivery strategies involving multiple therapeutic payloads. Representative applications of DNA nanostructures and AS1411-functionalized nanocarriers in preclinical cancer research are reviewed, with attention to their delivery mechanisms and potential limitations. Furthermore, analytical characterization, drug-release behavior, carrier stability, and major challenges in clinical translation are considered. Although these approaches have demonstrated promising results in preclinical studies, further investigation of their pharmacokinetics, safety, reproducibility, and therapeutic efficacy is required to support clinical development.

Biomedical AnalysisVol. 3(4)
Inner Mongolia Normal University (CN), Inner Mongolia People's Hospital (CN), Inner Mongolia Medical University (CN)
National Natural Science Foundation of China, Natural Science Foundation of Inner Mongolia
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon